30 results
8-K
EX-10.1
BPTH
Bio-Path Holdings Inc
19 Apr 24
Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the- Market Under Nasdaq Rules
9:21am
of, the testing of, the sale of, or the labeling and promotion of any Pharmaceutical Product, (ii) withdraws its approval of, requests the recall, suspension
8-K
EX-10.1
BPTH
Bio-Path Holdings Inc
4 Apr 24
Entry into a Material Definitive Agreement
4:35pm
the recall, suspension, or seizure of, or withdraws or orders the withdrawal of advertising or sales promotional materials relating to, any Pharmaceutical
8-K
EX-10.1
BPTH
Bio-Path Holdings Inc
26 Mar 24
Entry into a Material Definitive Agreement
8:03am
and promotion of any Pharmaceutical Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws or orders
8-K
EX-10.2
zcspwgrpm foqr
7 Aug 23
Bio-Path Holdings, Inc. Announces Pricing of $2.1 Million Public Offering
4:42pm
8-K
EX-10.1
nx77 8rub5nm873
9 Nov 22
Entry into a Material Definitive Agreement
8:30am
8-K
EX-99.2
2utga9
9 Nov 22
Entry into a Material Definitive Agreement
8:30am
8-K
EX-10.1
nwv3a0
17 Feb 21
Placement Agency Agreement
5:11pm
8-K
EX-10.1
20kyfr 1jy1my7u
14 Jul 20
Entry into a Material Definitive Agreement
6:05am
8-K
EX-10.1
a58bm1n
22 Nov 19
Entry into a Material Definitive Agreement
5:25pm
8-K
EX-10.1
fzfbodaj9
13 Mar 19
Entry into a Material Definitive Agreement
4:24pm
8-K
EX-10.1
ccveip
22 Jan 19
Entry into a Material Definitive Agreement
4:46pm
8-K
EX-1.1
pf1t499gkiq6 vfw
16 Jan 19
Bio-Path Holdings, Inc. Announces Proposed Public Offering of Common Stock
5:25pm
8-K
EX-10.1
97tp8rggdj l1
21 Sep 18
Entry into a Material Definitive Agreement
5:28pm
8-K
EX-10.1
sgplq9 xxax8gay
21 Jan 14
Bio-Path Holdings, Inc. to Raise $10 Million in Registered Direct Offering
12:00am